Literature DB >> 12917432

Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein.

Fabian Sokolowski1, Andreas Johannes Modler, Ralf Masuch, Dietrich Zirwer, Michael Baier, Gudrun Lutsch, David Alan Moss, Klaus Gast, Dieter Naumann.   

Abstract

We have investigated the conformational transition and aggregation process of recombinant Syrian hamster prion protein (SHaPrP90-232) by Fourier transform infrared spectroscopy, circular dichroism spectroscopy, light scattering, and electron microscopy under equilibrium and kinetic conditions. SHaPrP90-232 showed an infrared absorbance spectrum typical of proteins with a predominant alpha-helical structure both at pH 7.0 and at pH 4.2 in the absence of guanidine hydrochloride. At pH 4.2 and destabilizing conditions (0.3-2 m guanidine hydrochloride), the secondary structure of SHaPrP90-232 was transformed to a strongly hydrogen-bonded, most probably intermolecularly arranged antiparallel beta-sheet structure as indicated by dominant amide I band components at 1620 and 1691 cm-1. Kinetic analysis of the transition process showed that the decrease in alpha-helical structures and the increase in beta-sheet structures occurred concomitantly according to a bimolecular reaction. However, the concentration dependence of the corresponding rate constant pointed to an apparent third order reaction. No beta-sheet structure was formed within the dead time (190 ms) of the infrared experiments. Light scattering measurements revealed that the structural transition of SHaPrP90-232 was accompanied by formation of oligomers, whose size was linearly dependent on protein concentration. Extrapolation to zero protein concentration yielded octamers as the smallest oligomers, which are considered as "critical oligomers." The small oligomers showed spherical and annular shapes in electron micrographs. Critical oligomers seem to play a key role during the transition and aggregation process of SHaPrP90-232. A new model for the structural transition and aggregation process of the prion protein is described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917432     DOI: 10.1074/jbc.M304391200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  The peculiar nature of unfolding of the human prion protein.

Authors:  Ilia V Baskakov; Giuseppe Legname; Zygmunt Gryczynski; Stanley B Prusiner
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

2.  Influence of the N-terminal domain on the aggregation properties of the prion protein.

Authors:  Kristen N Frankenfield; Evan T Powers; Jeffery W Kelly
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

3.  Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Authors:  Sara Vasan; Phyllus Y Mong; Abraham Grossman
Journal:  Neurochem Res       Date:  2006-06-02       Impact factor: 3.996

4.  The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the "supercritical concentration".

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2006-04-07       Impact factor: 4.033

5.  Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.

Authors:  Frederic Eghiaian; Thorsten Daubenfeld; Yann Quenet; Marieke van Audenhaege; Anne-Pascale Bouin; Guillaume van der Rest; Jeanne Grosclaude; Human Rezaei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-18       Impact factor: 11.205

6.  Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation.

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

7.  Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP.

Authors:  M Qasim Khan; Braden Sweeting; Vikram Khipple Mulligan; Pharhad Eli Arslan; Neil R Cashman; Emil F Pai; Avijit Chakrabartty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

8.  Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.

Authors:  Pelagia Deriziotis; Ralph André; David M Smith; Rob Goold; Kerri J Kinghorn; Mark Kristiansen; James A Nathan; Rina Rosenzweig; Dasha Krutauz; Michael H Glickman; John Collinge; Alfred L Goldberg; Sarah J Tabrizi
Journal:  EMBO J       Date:  2011-07-08       Impact factor: 11.598

9.  Sensitive detection of aggregated prion protein via proximity ligation.

Authors:  Maria Hammond; Lotta Wik; Jean-Philippe Deslys; Emmanuel Comoy; Tommy Linné; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  Prion       Date:  2014       Impact factor: 3.931

10.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.